| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 1166-1179, Copyright © 1995 by Endocrine Society
ARTICLES |
GK Whitfield, JC Hsieh, S Nakajima, PN MacDonald, PD Thompson, PW Jurutka, CA Haussler and MR Haussler
Department of Biochemistry, University of Arizona College of Medicine, Tucson 85724, USA.
Residues located between amino acids 244 and 263 in the human vitamin D receptor (hVDR) show extensive homology with other members of the steroid/thyroid/retinoid hormone receptor superfamily. The corresponding region of the glucocorticoid receptor has been shown to interact with the 90-kilodalton heat shock protein (hsp90), yet hVDR does not appear to bind to hsp90. Herein we report a study of hVDR in which the functional role of five conserved residues was tested by replacing Phe-244, Lys-246, Leu-254, Gln-259, and Leu-262 with glycines by site-directed mutagenesis. Initial screening of these mutants indicated that all were significantly impaired in their ability to activate transcription from a vitamin D-responsive reporter construct when expressed in transfected VDR-deficient COS-7 cells. Further characterization revealed two classes of mutants: the predominant class binds the 1,25-dihydroxyvitamin D3 ligand normally but is defective in its ability to form a heterodimeric complex with the retinoid X receptor (RXR) on a vitamin D responsive element (VDRE). A second unique class, represented by a single mutant at Lys-246, is normal both with respect to ligand binding and complex formation but still very impaired in transactivation ability. The distinction between these two classes was confirmed by the demonstration that a member of the first class, with a mutation at Gln-259, could be restored to near wild type transactivation ability by supplying excess RXR, while the Lys-246 mutant could not be so rescued. We therefore conclude that the primary function of this conserved domain in hVDR is the mediation of heterodimerization with RXR, leading to VDRE binding and transactivation. The possibility also exists that the Lys-246 mutant may be impaired in a step of transactivation that is distal to complex formation with RXR on the VDRE, perhaps in interactions with the transcriptional machinery itself.
This article has been cited by other articles:
![]() |
P. J. Malloy, R. Xu, L. Peng, S. Peleg, A. Al-Ashwal, and D. Feldman Hereditary 1,25-Dihydroxyvitamin D Resistant Rickets due to a Mutation Causing Multiple Defects in Vitamin D Receptor Function Endocrinology, November 1, 2004; 145(11): 5106 - 5114. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chen, Q. Wang, X. Wang, and G. P. Studzinski Up-Regulation of Egr1 by 1,25-Dihydroxyvitamin D3 Contributes to Increased Expression of p35 Activator of Cyclin-Dependent Kinase 5 and Consequent Onset of the Terminal Phase of HL60 Cell Differentiation Cancer Res., August 1, 2004; 64(15): 5425 - 5433. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Barry, G. M. Leong, W. B. Church, L. L. Issa, J. A. Eisman, and E. M. Gardiner Interactions of SKIP/NCoA-62, TFIIB, and Retinoid X Receptor with Vitamin D Receptor Helix H10 Residues J. Biol. Chem., February 28, 2003; 278(10): 8224 - 8228. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Malloy, R. Xu, L. Peng, P. A. Clark, and D. Feldman A Novel Mutation in Helix 12 of the Vitamin D Receptor Impairs Coactivator Interaction and Causes Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets without Alopecia Mol. Endocrinol., November 1, 2002; 16(11): 2538 - 2546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, J. Cui, K. Nakamura, R. C. J. Ribeiro, B. L. West, and D. G. Gardner Coactivator-Vitamin D Receptor Interactions Mediate Inhibition of the Atrial Natriuretic Peptide Promoter J. Biol. Chem., May 12, 2000; 275(20): 15039 - 15048. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Jurutka, L. S. Remus, G. K. Whitfield, P. D. Thompson, J.-C. Hsieh, H. Zitzer, P. Tavakkoli, M. A. Galligan, H. T. L. Dang, C. A. Haussler, et al. The Polymorphic N Terminus in Human Vitamin D Receptor Isoforms Influences Transcriptional Activity by Modulating Interaction with Transcription Factor IIB Mol. Endocrinol., March 1, 2000; 14(3): 401 - 420. [Abstract] [Full Text] |
||||
![]() |
A. M. Jimenez-Lara and A. Aranda Lysine 246 of the Vitamin D Receptor Is Crucial for Ligand-dependent Interaction with Coactivators and Transcriptional Activity J. Biol. Chem., May 7, 1999; 274(19): 13503 - 13510. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, C. H. R. M. Costa, K. Nakamura, R. C. J. Ribeiro, and D. G. Gardner Vitamin D-dependent Suppression of Human Atrial Natriuretic Peptide Gene Promoter Activity Requires Heterodimer Assembly J. Biol. Chem., April 16, 1999; 274(16): 11260 - 11266. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Malloy, J. W. Pike, and D. Feldman The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets Endocr. Rev., April 1, 1999; 20(2): 156 - 188. [Abstract] [Full Text] |
||||
![]() |
G. JONES, S. A. STRUGNELL, and H. F. DeLUCA Current Understanding of the Molecular Actions of Vitamin D Physiol Rev, October 1, 1998; 78(4): 1193 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raval-Pandya, L. P. Freedman, H. Li, and S. Christakos Thyroid Hormone Receptor Does Not Heterodimerize with the Vitamin D Receptor but Represses Vitamin D Receptor-Mediated Transactivation Mol. Endocrinol., September 1, 1998; 12(9): 1367 - 1379. [Abstract] [Full Text] |
||||
![]() |
W. Feng, R. C. Ribeiro, R. L. Wagner, H. Nguyen, J. W. Apriletti, R. J. Fletterick, J. D. Baxter, P. J. Kushner, and B. L. West Hormone-Dependent Coactivator Binding to a Hydrophobic Cleft on Nuclear Receptors Science, June 12, 1998; 280(5370): 1747 - 1749. [Abstract] [Full Text] |
||||
![]() |
S. Chen, J. Wu, J.-C. Hsieh, G. K. Whitfield, P. W. Jurutka, M. R. Haussler, and D. G. Gardner Suppression of ANP Gene Transcription by Liganded Vitamin D Receptor : Involvement of Specific Receptor Domains Hypertension, June 1, 1998; 31(6): 1338 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Towers and L. P. Freedman Granulocyte-Macrophage Colony-stimulating Factor Gene Transcription Is Directly Repressed by the Vitamin D3 Receptor. IMPLICATIONS FOR ALLOSTERIC INFLUENCES ON NUCLEAR RECEPTOR STRUCTURE AND FUNCTION BY A DNA ELEMENT J. Biol. Chem., April 24, 1998; 273(17): 10338 - 10348. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Cockerill, N. S. Hawa, N. Yousaf, M. Hewison, J. L H. O'Riordan, and S. M. Farrow Mutations in the Vitamin D Receptor Gene in Three Kindreds Associated with Hereditary Vitamin D Resistant Rickets J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3156 - 3160. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Masuyama, C. M. Brownfield, R. St-Arnaud, and P. N. MacDonald Evidence for Ligand-Dependent Intramolecular Folding of the AF-2 Domain in Vitamin D Receptor-Activated Transcription and Coactivator Interaction Mol. Endocrinol., September 1, 1997; 11(10): 1507 - 1517. [Abstract] [Full Text] |
||||
![]() |
P. W. Jurutka, J.-C. Hsieh, L. S. Remus, G. K. Whitfield, P. D. Thompson, C. A. Haussler, J. C. G. Blanco, K. Ozato, and M. R. Haussler Mutations in the 1,25-Dihydroxyvitamin D3 Receptor Identifying C-terminal Amino Acids Required for Transcriptional Activation That Are Functionally Dissociated from Hormone Binding, Heterodimeric DNA Binding, and Interaction with Basal Transcription Factor IIB, in Vitro J. Biol. Chem., June 6, 1997; 272(23): 14592 - 14599. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Li, C. Bergwitz, H. Juppner, and M. B. Demay Cloning and Characterization of the Vitamin D Receptor from Xenopus laevis Endocrinology, June 1, 1997; 138(6): 2347 - 2353. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Liu, E. D. Collins, A. W. Norman, and S. Peleg Differential Interaction of 1alpha ,25-Dihydroxyvitamin D3 Analogues and Their 20-epi Homologues with the Vitamin D Receptor J. Biol. Chem., February 7, 1997; 272(6): 3336 - 3345. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Sneddon, C. E. Bogado, M. S. Kiernan, and M. B. Demay DNA Sequences Downstream from the Vitamin D Response Element of the Rat Osteocalcin Gene Are Required for Ligand-Dependent Transactivation Mol. Endocrinol., February 1, 1997; 11(2): 210 - 217. [Abstract] [Full Text] |
||||
![]() |
S. Nakajima, J.-C. Hsieh, P. W. Jurutka, M. A. Galligan, C. A. Haussler, G. K. Whitfield, and M. R. Haussler Examination of the Potential Functional Role of Conserved Cysteine Residues in the Hormone Binding Domain of the Human 1,25-Dihydroxyvitamin D(3) Receptor J. Biol. Chem., March 1, 1996; 271(9): 5143 - 5149. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Prufer, A. Racz, G. C. Lin, and J. Barsony Dimerization with Retinoid X Receptors Promotes Nuclear Localization and Subnuclear Targeting of Vitamin D Receptors J. Biol. Chem., December 22, 2000; 275(52): 41114 - 41123. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Gardezi, C. Nguyen, P. J. Malloy, G. H. Posner, D. Feldman, and S. Peleg A Rationale for Treatment of Hereditary Vitamin D-resistant Rickets with Analogs of 1alpha ,25-Dihydroxyvitamin D3 J. Biol. Chem., July 27, 2001; 276(31): 29148 - 29156. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |